Valeant Pharmaceuticals International, Inc. announced that effective December 16, 2011, the company completed its previously announced acquisition of Dermik, a dermatology unit of Sanofi.

The transaction includes businesses in the US and Canada, as well as a global business. Sanofi said that the deal also includes its Laval, Canada site, which includes Dermik’s manufacturing facility. Sales from the Dermik unit are expected to be more than $200M this year.

Sanofi said that its Canadian unit will maintain operations in Montreal.